The Inflation Reduction Act will ultimately raise drug costs and reduce future cures.
FDA Hurts Patients By Authorizing Florida’s Drug Importation Program
On January 5, 2024, the U.S. FDA authorized Florida’s drug importation program.
Misguided Use of March-In Rights Will Harm Patients
The use of march-in rights to steal intellectual property will neither lower costs nor create more access to healthcare.
Biden Price Controls Kill Innovation and Patients
IRA drug price controls will devastate future drug development, resulting in more lives lost.
Congress Should not Double Down on Devastating Drug Price Controls
House Democrats’ new bill on price controls will devastate future drug development and raise costs.
Biden’s Budget and the SMART Prices Act Will Devastate Drug Development
Pharmaceutical price controls in President Biden’s budget and the SMART Choices Act will devastate drug development.
Patients Pay the Ultimate Price for Price Controls
Price controls on pharmaceuticals distort the medical marketplace and will not lower drug prices.
New Study Confirms 340B Program is Exploited
A new study, “340B and Health Equity: A Missed Opportunity in Medically Underserved Areas,” shows the program is misused.
Vote NO on AB 215 – Pharmaceutical – Nevada
Nevada State Assembly 401 South Carson Street Carson City, Nevada 89701-4747 Dear Assembly Member, AB 215, a so-called pharmaceutical price transparency bill, was introduced on February 13, 2017 and is currently being considered by the Assembly Committee on Health and Human Services. It would require pharmaceutical companies to provide to the Division of Insurance an […]